Pomerantz Law Firm Launches Investigation into Globus Medical Investors' Concerns
Pomerantz Law Firm Investigates Globus Medical, Inc.
Pomerantz LLP, a well-respected legal firm specializing in class action lawsuits, has initiated an investigation focused on claims made by investors of Globus Medical, Inc. (NYSE: GMED). Investors are urged to reach out to the firm for more information regarding potential legal action.
Background on the Investigation
Pomerantz's inquiry centers on allegations that certain officers and directors of Globus may have been involved in securities fraud and other unlawful practices. The concern comes in light of disappointing financial results disclosed by the company, which have sparked anxiety among shareholders.
On May 8, 2025, Globus Medical released its financial results for the first quarter of the fiscal year, revealing that the company's earnings per share were $0.68, falling short of expectations by $0.06. Additionally, the revenue reported was $598.12 million, which represented a shortfall of $27.78 million compared to projections, marking a 1.4% decline compared to the same quarter the previous year.
Factors Affecting Financial Performance
During a conference call following the announcement, the President and CEO of Globus attributed the results adversely impacted to several factors, including delays in